173 related articles for article (PubMed ID: 24858729)
1. Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency.
Chen B; Liu DL; Pan WY; Yang XH; Shou JB; Wu JH; Mao QL; Wang J
Mol Med Rep; 2014 Aug; 10(2):593-8. PubMed ID: 24858729
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid and dimethyl sulfoxide promote efficient delivery of transgenes to mouse skin by topically transdermal penetration.
Chen X; Zhang Y; Liu C; Zhang Y; Zhou X; Zhou T; Mao Y; Kan B; Wei YQ; Li J
Drug Deliv; 2010 Aug; 17(6):385-90. PubMed ID: 20500128
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib.
Senna TD; Mata Dos Santos HA; Kibwila DM; Leitao AC; Santos Pyrrho AD; de Padula M; Rosas EC; Padua TA; Lara MG; Riemma Pierre MB
Curr Drug Deliv; 2017; 14(7):992-1004. PubMed ID: 28124617
[TBL] [Abstract][Full Text] [Related]
4. The effect of hydrophilic penetration/diffusion enhancer on stratum corneum lipid models: Part II*: DMSO.
Mueller J; Trapp M; Neubert RHH
Chem Phys Lipids; 2019 Dec; 225():104816. PubMed ID: 31525381
[TBL] [Abstract][Full Text] [Related]
5. In-vitro release and transdermal fluxes of a highly lipophilic drug and of enhancers from matrix TDS.
Funke AP; Günther C; Müller RH; Lipp R
J Control Release; 2002 Jul; 82(1):63-70. PubMed ID: 12106977
[TBL] [Abstract][Full Text] [Related]
6. Combination effect of penetration enhancers and propylene glycol on in vitro transdermal absorption of insulin.
Príborský J; Takayama K; Nagai T; Waitzová D; Elis J
Drug Des Deliv; 1987 Dec; 2(2):91-7. PubMed ID: 3334547
[TBL] [Abstract][Full Text] [Related]
7. Transdermal drug delivery of labetalol hydrochloride: Feasibility and effect of penetration enhancers.
Zafar S; Ali A; Aqil M; Ahad A
J Pharm Bioallied Sci; 2010 Oct; 2(4):321-4. PubMed ID: 21180464
[TBL] [Abstract][Full Text] [Related]
8. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
[TBL] [Abstract][Full Text] [Related]
9. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
11. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of the Transdermal Permeation Effectiveness of Fu's Cupping Therapy on Eight Different Types of Model Drugs.
Miao Y; Xu J; Liu Y; Yang F; Zheng X; Xie W; Zhang Y
Curr Drug Deliv; 2021; 18(4):446-459. PubMed ID: 33200698
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
Kanikkannan N; Kandimalla K; Lamba SS; Singh M
Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
[TBL] [Abstract][Full Text] [Related]
14. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
Shin SC; Lee HJ
Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
[TBL] [Abstract][Full Text] [Related]
15. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
[TBL] [Abstract][Full Text] [Related]
16. The effects of some permeability enhancers on the percutaneous absorption of lidocaine.
Mohammadi-Samani S; Jamshidzadeh A; Montaseri H; Rangbar-Zahedani M; Kianrad R
Pak J Pharm Sci; 2010 Jan; 23(1):83-8. PubMed ID: 20067872
[TBL] [Abstract][Full Text] [Related]
17. Dermal peptide delivery using enhancer molecules and colloidal carrier systems - part V
Foerster A; Neubert RHH
Pharmazie; 2019 Mar; 74(3):136-141. PubMed ID: 30961677
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of contraceptives.
Friend DR
Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin.
Kurihara-Bergstrom T; Flynn GL; Higuchi WI
J Invest Dermatol; 1987 Sep; 89(3):274-80. PubMed ID: 3624900
[TBL] [Abstract][Full Text] [Related]
20. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]